{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:57:07Z","timestamp":1788875827246,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":836,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007825","name":"American College of Veterinary Internal Medicine","doi-asserted-by":"publisher","award":["25532"],"award-info":[{"award-number":["25532"]}],"id":[{"id":"10.13039\/100007825","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michigan State University College of Veterinary Medicine","award":["6119824524"],"award-info":[{"award-number":["6119824524"]}]},{"DOI":"10.13039\/100007825","name":"American College of Veterinary Internal Medicine","doi-asserted-by":"publisher","award":["25532"],"award-info":[{"award-number":["25532"]}],"id":[{"id":"10.13039\/100007825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment with phenylbutazone (nonselective COX inhibitor) decreases the diuretic and natriuretic effects of furosemide by nearly 30% but the effects of COX-2 specific inhibitors (firocoxib) and atypical NSAIDs (dipyrone) are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Furosemide-induced diuresis after pretreatment with firocoxib or dipyrone is diminished to a lesser extent than after pretreatment with phenylbutazone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Eight healthy mares.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Each mare received 4 treatments in a prospective experimental crossover study using a replicated 4 \u00d7\u20094 Latin Square design: furosemide alone (FU), furosemide and phenylbutazone (PB), furosemide and firocoxib (FX), and furosemide and dipyrone (DP). After 24\u2009hours of NSAID treatment at recommended dosages, ureteral catheters were placed for continual urine collection. After a 30-minute baseline collection period, furosemide (1.0\u2009mg\/kg, IV) was administered, and urine and blood samples were collected for 4\u2009hours. Data were assessed by repeated measures ANOVA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four-hour urine volume was (mean\u2009\u00b1\u2009SD) ~25% less (P\u2009&amp;lt;\u2009.001) after pretreatment with all NSAIDs (PB 19.1\u2009\u00b1\u20092.1\u2009mL\/kg, FX 17.7\u2009\u00b1\u20093.5\u2009mL\/kg, DP 19.1\u2009\u00b1\u20093.9\u2009mL\/kg), as compared to FU (23.4\u2009\u00b1\u20095.1\u2009mL\/kg) (P\u2009&amp;lt;\u2009.001), but there were no differences between PB, FX, or DP. Interindividual variability in furosemide diuresis after pretreatment with different NSAIDs was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Though COX-2 selective NSAIDs and dipyrone might have less severe or fever gastrointestinal adverse effects in horses, our data suggest minimal differences in effects on furosemide-induced diuresis, and possibly, risk of nephrotoxicosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.16914","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:15:50Z","timestamp":1698300950000},"page":"2544-2551","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-2236","authenticated-orcid":false,"given":"Julianne M.","family":"White","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Large Animal Clinical Sciences, , East Lansing, Michigan,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-405X","authenticated-orcid":false,"given":"Aimee C.","family":"Colbath","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Large Animal Clinical Sciences, , East Lansing, Michigan,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-5409","authenticated-orcid":false,"suffix":"II","given":"Harold C.","family":"Schott","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Large Animal Clinical Sciences, , East Lansing, Michigan,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"2026021401280409900_jvim16914-bib-0001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2460\/javma.1993.202.01.71","article-title":"Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses","volume":"202","author":"MacAllister","year":"1993","journal-title":"J Am Vet Med Assoc"},{"key":"2026021401280409900_jvim16914-bib-0002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.HYP.0000116221.27079.ea","article-title":"Cyclooxygenases, the kidney, and hypertension","volume":"43","author":"Cheng","year":"2004","journal-title":"Hypertension"},{"key":"2026021401280409900_jvim16914-bib-0003","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","article-title":"Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney","volume":"34","author":"N\u00f8rregaard","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"2026021401280409900_jvim16914-bib-0004","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.3390\/ijms18122539","article-title":"Prostaglandin E2 in the regulation of water transport in renal collecting ducts","volume":"18","author":"Li","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026021401280409900_jvim16914-bib-0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1939-1676.1991.tb00951.x","article-title":"Pharmacology of furosemide in the horse: a review","volume":"5","author":"Hinchcliff","year":"1991","journal-title":"J Vet Intern Med"},{"key":"2026021401280409900_jvim16914-bib-0006","doi-asserted-by":"crossref","first-page":"F958","DOI":"10.1152\/ajprenal.00476.2015","article-title":"Everything we always wanted to know about furosemide but were afraid to ask","volume":"310","author":"Huang","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026021401280409900_jvim16914-bib-0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1755.2001.00466.x","article-title":"Furosemide stimulates macula densa cyclooxygenase-2 expression in rats","volume":"59","author":"Mann","year":"2001","journal-title":"Kidney Int"},{"key":"2026021401280409900_jvim16914-bib-0008","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2460\/ajvr.1995.56.09.1206","article-title":"Pharmacologic interaction of furosemide and phenylbutazone in horses","volume":"56","author":"Hinchcliff","year":"1995","journal-title":"Am J Vet Res"},{"key":"2026021401280409900_jvim16914-bib-0009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2042-3306.1999.tb03819.x","article-title":"Attenuation by phenylbutazone of the renal effects and excretion of frusemide in horses","volume":"31","author":"Dyke","year":"1999","journal-title":"Equine Vet J"},{"key":"2026021401280409900_jvim16914-bib-0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2460\/ajvr.75.7.668","article-title":"Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses","volume":"75","author":"Raidal","year":"2014","journal-title":"Am J Vet Res"},{"key":"2026021401280409900_jvim16914-bib-0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2460\/javma.232.1.91","article-title":"Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis","volume":"232","author":"Doucet","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"2026021401280409900_jvim16914-bib-0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2026021401280409900_jvim16914-bib-0013","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.18501120","article-title":"Comparative risks of nonsteroidal anti-inflammatory drugs on CKD","volume":"16","author":"Wan","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026021401280409900_jvim16914-bib-0014","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12917-015-0598-z","article-title":"Effect of cyclooxygenase (COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney","volume":"11","author":"Pelligand","year":"2015","journal-title":"BMC Vet Res"},{"key":"2026021401280409900_jvim16914-bib-0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10157-009-0214-2","article-title":"Effects of selective COX-2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal COX-2 expression in rats","volume":"14","author":"Kose","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"2026021401280409900_jvim16914-bib-0016","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2460\/ajvr.80.3.294","article-title":"Randomized blinded controlled trial of dipyrone as a treatment for pyrexia in horses","volume":"80","author":"Morresey","year":"2019","journal-title":"Am J Vet Res"},{"key":"2026021401280409900_jvim16914-bib-0017","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/EJA.0000000000000627","article-title":"The use of dipyrone in the ICU is associated with acute kidney injury","volume":"34","author":"Stueber","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"2026021401280409900_jvim16914-bib-0018","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.2042-3292.1990.tb01420.x","article-title":"Ureteral catheterisation in the horse","volume":"2","author":"Schott","year":"1990","journal-title":"Equine Vet Educ"},{"key":"2026021401280409900_jvim16914-bib-0019","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2460\/ajvr.1988.49.11.1899","article-title":"Influence of furosemide treatment on fluid and electrolyte balance in horses","volume":"49","author":"Freestone","year":"1988","journal-title":"Am J Vet Res"},{"key":"2026021401280409900_jvim16914-bib-0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2885.1991.tb00855.x","article-title":"Furosemide-induced changes in plasma and blood volume of horses","volume":"14","author":"Hinchcliff","year":"1991","journal-title":"J Vet Pharmacol Ther"},{"key":"2026021401280409900_jvim16914-bib-0021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.2042-3306.2006.tb05547.x","article-title":"Frusemide results in an extracellular to intracellular fluid shift in horses","volume":"36","author":"Forro","year":"2006","journal-title":"Equine Vet J Suppl"},{"key":"2026021401280409900_jvim16914-bib-0022","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00432.2014","article-title":"Physiology and pathophysiology of the renal Na-K-2Cl cotransporter (NKCC2)","volume":"307","author":"Castrop","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026021401280409900_jvim16914-bib-0023","first-page":"F555","article-title":"Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2","volume":"247","author":"Katayama","year":"1984","journal-title":"Am J Physiol"},{"key":"2026021401280409900_jvim16914-bib-0024","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0022-3565(25)21067-9","article-title":"Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop","volume":"251","author":"Miyanoshita","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"2026021401280409900_jvim16914-bib-0025","first-page":"F165","article-title":"Antagonists of the antidiuretic activity of vasopressin","volume":"254","author":"Kinter","year":"1988","journal-title":"Am J Physiol"},{"key":"2026021401280409900_jvim16914-bib-0026","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1046\/j.1523-1755.2001.00988.x","article-title":"Inhibition of COX-2 counteracts the effects of diuretics in rats","volume":"60","author":"Kammerl","year":"2001","journal-title":"Kidney Int"},{"key":"2026021401280409900_jvim16914-bib-0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.787598","article-title":"A vasopressin-induced change in prostaglandin receptor subtype expression explains the differential effect of PGE2 on AQP2 expression","volume":"12","author":"Deen","year":"2022","journal-title":"Front Physiol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/37\/6\/2544\/66895494\/jvim16914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/37\/6\/2544\/66895494\/jvim16914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:28:09Z","timestamp":1771050489000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/37\/6\/2544\/8483264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.16914","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"2023-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}